Robert W. Hesslein, Senior VP & General Counsel at Voyager Therapeutics, Inc. (VYGR), sold 3,297 shares at $7.45 ($25K) on 2023-02-17, disclosed to the SEC on 2023-02-22.
Scheduled sale ($25k) by Senior VP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VYGR | SELL | 2023-01-19 | $22K | — | Filing → |
| VYGR | SELL | 2022-04-06 | $23K | — | Filing → |
| VYGR | SELL | 2022-03-23 | $41K | — | Filing → |